Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Latest filing published 18 Aug 2026 for Pacific Biosciences of California, INC., €26k. Read the official filing
Filing timeline
BuySaleMark Van Oene
Insider track record
Disclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark Van Oene: trading record in brief
Mark Van Oene appears in our data through filings on Pacific Biosciences of California, Inc. shares, published by SEC (Form 4). Between 11 January 2022 and 17 August 2026, the trades on record add up to 21 filings.
The open-market record consists of 14 sales worth €2.0M, with no purchase. Besides market trades, the filings include 7 share grants. 2026 to date brings no purchases and 3 sales.
The newest entry dates from 18 August 2026: an open-market sale of €26k, in Pacific Biosciences of California, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark Van Oene
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
26,911 shares@ US$1.13Common StockSEC:0001299130-26-000128:0
489,130 shares0Common StockSEC:0001299130-26-000126:0
6,504 shares@ US$1.5140.4% of flowCommon StockSEC:0001299130-26-000042:0
500,000 shares0Common StockSEC:0001299130-26-000038:0
129,790 shares@ US$1.5760.050% mcap12.4% of flowCommon StockSEC:0001299130-26-000023:0
26,836 shares@ US$1.3111.5% of flowCommon StockSEC:0001299130-25-000160:0
449,176 shares0Common StockSEC:0001299130-25-000068:0
6,486 shares@ US$1.4070.3% of flowCommon StockSEC:0001299130-25-000047:0
100,773 shares@ US$1.8786.8% of flowCommon StockSEC:0001299130-25-000038:0
34,405 shares@ US$2.0342.6% of flowCommon StockSEC:0001299130-25-000006:0
38,011 shares@ US$1.6622.2% of flowCommon StockSEC:0001299130-24-000172:0
9,186 shares@ US$4.8711.6% of flowCommon StockSEC:0001299130-24-000072:0
798,076 shares0Common StockSEC:0001299130-24-000044:0
33,560 shares@ US$5.9587.0% of flowCommon StockSEC:0001299130-24-000029:0
31,012 shares@ US$7.7738.3% of flowCommon StockSEC:0001299130-24-000008:0
26,102 shares@ US$11.0010.0% of flowCommon StockSEC:0001299130-23-000107:0
328,500 shares0Common StockSEC:0001299130-23-000040:0
26,722 shares@ US$9.5349.0% of flowCommon StockSEC:0001299130-23-000012:0
300,000 shares0Common StockSEC:0001299130-22-000108:0
72,500 shares0Common StockSEC:0001299130-22-000035:0
41,480 shares@ US$14.2326.1% of flowCommon StockSEC:0001299130-22-000012:0
21 of 21 declarations
